Maze Therapeutics MAZE Total debt

Total debt at other companies

Vertex PharmaceuticalsVRTX

$1.98B+29.5%

Septerna, Inc.SEPN

$22.55M-8.2%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

Olema Pharmaceuticals, Inc.OLMA

$956K-16.7%

Nurix Therapeutics, Inc.NRIX

$58.14M+12.0%

Apogee Therapeutics, Inc.APGE

$8.05M-31.9%

FAQ

What is Maze Therapeutics's total debt?

Maze Therapeutics (MAZE) reported total debt of $60.42M in Q2 2026.

How has Maze Therapeutics's total debt changed year-over-year?

Maze Therapeutics's total debt increased by 141.6% year-over-year, from $25.01M to $60.42M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.